|
3LBS
Crystal structure of the cytoplasmic tail of (pro)renin receptor as a MBP fusion (Maltose-bound form)
提交 2010-01-08
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
332–349(18 aa)
片段:Maltose-binding periplasmic protein, residues 29-390, Renin receptor, residues 332-350
链 B
332–349(18 aa)
片段:Maltose-binding periplasmic protein, residues 29-390, Renin receptor, residues 332-350
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;pH 6.5;293 K;28% PEG4000, 0.2M Magnesium Chloride, 0.1 M Cacodylate, pH 6.5, EVAPORATION, temperature 293K
|
分辨率 2.15 Å
R-free 0.278
|
|
3LC8
Crystal structure of the cytoplasmic tail of (pro)renin receptor as a MBP fusion (Maltose-free form)
提交 2010-01-10
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
信息不足
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
332–349(18 aa)
片段:Maltose-binding periplasmic protein, residues 29-390, Renin receptor, residues 332-350
链 B
332–349(18 aa)
片段:Maltose-binding periplasmic protein, residues 29-390, Renin receptor, residues 332-350
|
未记录
|
PG4 TETRAETHYLENE GLYCOL × 2
GOL GLYCEROL × 3
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;pH 8.5;293 K;20% PEG 4000, 0.2M Magnesium Chloride, 0.1M Tris, pH 8.5, EVAPORATION, temperature 293K
|
分辨率 2.00 Å
R-free 0.257
|
|
6WLW
The Vo region of human V-ATPase in state 1 (focused refinement)
提交 2020-04-20
|
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 16
PDB 声明:hexadecameric
|
链 V
1–350(350 aa)
|
未记录
|
WSS tri(methyl)-[2-[[(2~{R})-2-[(~{Z})-octadec-9-enoyl]oxy-3-[(~{E})-1-oxidanylideneoctadec-9-enoxy]propoxy]-oxidanyl-phosphoryl]oxyethyl]azanium × 10
PTY PHOSPHATIDYLETHANOLAMINE × 13
WJS (2~{S})-2-$l^{4}-azanyl-3-[[(2~{R})-3-octadecanoyloxy-2-oxidanyl-propoxy]-oxidanyl-oxidanylidene-$l^{6}-phosphanyl]oxy-propanoic acid × 1
CLR CHOLESTEROL × 4
PSF 1,2-DICAPROYL-SN-PHOSPHATIDYL-L-SERINE × 1
WJP methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.00 Å
|
|
6WM2
Human V-ATPase in state 1 with SidK and ADP
提交 2020-04-20
|
聚集状态不同
配体/离子不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 35
PDB 声明:35-meric
|
链 V
1–350(350 aa)
|
未记录
|
CLR CHOLESTEROL × 4
PSF 1,2-DICAPROYL-SN-PHOSPHATIDYL-L-SERINE × 1
PTY PHOSPHATIDYLETHANOLAMINE × 13
WSS tri(methyl)-[2-[[(2~{R})-2-[(~{Z})-octadec-9-enoyl]oxy-3-[(~{E})-1-oxidanylideneoctadec-9-enoxy]propoxy]-oxidanyl-phosphoryl]oxyethyl]azanium × 10
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
WJP methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate × 1
ADP ADENOSINE-5'-DIPHOSPHATE × 1
WJS (2~{S})-2-$l^{4}-azanyl-3-[[(2~{R})-3-octadecanoyloxy-2-oxidanyl-propoxy]-oxidanyl-oxidanylidene-$l^{6}-phosphanyl]oxy-propanoic acid × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.10 Å
|
|
6WM3
Human V-ATPase in state 2 with SidK and ADP
提交 2020-04-20
|
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 35
PDB 声明:35-meric
|
链 V
1–350(350 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.40 Å
|
|
7U4T
Human V-ATPase in state 2 with SidK and mEAK-7
提交 2022-03-01
|
聚集状态不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 36
PDB 声明:36-meric
|
链 V
1–350(350 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.60 Å
|
|
9CF8
Cryo-EM structure of human kidney V-ATPase state 1
提交 2024-06-27
|
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 30
PDB 声明:30-meric
|
链 V
1–350(350 aa)
|
未记录
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.46 Å
|
|
9CFC
Cryo-EM structure of human kidney V-ATPase state 2
提交 2024-06-27
|
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 30
PDB 声明:30-meric
|
链 V
1–350(350 aa)
|
未记录
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.47 Å
|
|
9DET
Human V-ATPase Vo subcomplex (containing subunit isoform a4) bound to nanobody and inhibitor
提交 2024-08-29
|
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 17
PDB 声明:17-meric
|
链 p
1–350(350 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
CLR CHOLESTEROL × 1
POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 3
A1A4Q Cladoniamide A × 9
WJP methyl (3R,6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraen-1-yl dihydrogen diphosphate × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.2;20 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 2 mM DTT, pH 7.2
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.00 Å
|